Sarborg Ltd 13D/13G Filings for Conduit Pharmaceuticals Inc. (CDT)

Sarborg Ltd 13D and 13G filings for Conduit Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-07
5:36 pm
Purchase
2025-03-31 13G Conduit Pharmaceuticals Inc.
CDT
Sarborg Ltd 123,596
16.400%
123,596increase
(New Position)
Filing